These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 37456916)

  • 1. Long term use of eltrombopag in children with chronic immune thrombocytopenia: extended real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology.
    Giordano P; Lassandro G; Barone A; Cesaro S; Fotzi I; Giona F; Gorio C; Maggio A; Miano M; Marzollo A; Nardi M; Pession A; Ruggiero A; Russo G; Saracco P; Spinelli M; Tolva A; Tornesello A; Palladino V; Del Vecchio GC
    Front Med (Lausanne); 2023; 10():1214308. PubMed ID: 37521342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and treatment responses of immune thrombocytopenia in patients with primary Sjögren syndrome.
    Sun F; Tang Q; Cheng W; Xie X; Li F; Chen J
    Int Immunopharmacol; 2023 Oct; 123():110716. PubMed ID: 37506503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is associated with poor outcomes of corticosteroid treatment in patients with primary immune thrombocytopenia.
    Zhang X; Liu Q; Liu A; Leng S; Wang X; Zhao R; Sheng Z; Feng Q; Yang X; Wang S; Hou M; Peng J; Feng G
    Br J Haematol; 2023 Oct; 203(2):295-303. PubMed ID: 37488467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the glycobiology of immune thrombocytopenia.
    Tiemeyer KH; Kuter DJ; Cairo CW; Hollenhorst MA
    Curr Opin Hematol; 2023 Nov; 30(6):210-218. PubMed ID: 37526945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-centre prospective study comparing efficacy and safety of apremilast with cyclosporine in moderate to severe atopic dermatitis.
    Vyas HR; Shah SR; Shah BJ; Parmar KS; Jangid N; Choudhary A; Gehlawat T; Mistry D
    Australas J Dermatol; 2023 Nov; 64(4):e333-e339. PubMed ID: 37488939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter.
    Shao X; Xu P; Ji L; Wu B; Zhan Y; Zhuang X; Ou Y; Hua F; Sun L; Li F; Wang X; Chen H; Cheng Y
    Clin Transl Med; 2023 Jul; 13(7):e1344. PubMed ID: 37488670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of melatonin for children and adolescents with chronic insomnia attributable to disorders beyond indication: a systematic review, meta-analysis and clinical recommendation.
    Edemann-Callesen H; Andersen HK; Ussing A; Virring A; Jennum P; Debes NM; Laursen T; Baandrup L; Gade C; Dettmann J; Holm J; Krogh C; Birkefoss K; Tarp S; Händel MN
    EClinicalMedicine; 2023 Jul; 61():102049. PubMed ID: 37457114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.
    Ollier N; Piel-Julian ML; Mahévas M; Viallard JF; Comont T; Chèze S; Audia S; Ebbo M; Terriou L; Lega JC; Jeandel PY; Bonnotte B; Michel M; Lapeyre-Mestre M; Godeau B; Moulis G
    Blood; 2023 Sep; 142(12):1099-1101. PubMed ID: 37478400
    [No Abstract]   [Full Text] [Related]  

  • 9. Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study.
    Oladapo A; Kolodny S; Vredenburg M; Swallow E; Goldschmidt D; Sarathy K; Lopez P; Maitland H; Yee J
    Ther Adv Hematol; 2023; 14():20406207231179856. PubMed ID: 37465395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin-induced hypertension is associated with the up-regulation of Na+-K+-2Cl- cotransporter (NKCC2).
    Capolongo G; Damiano S; Suzumoto Y; Zacchia M; Rizzo M; Zona E; Pollastro RM; Simeoni M; Ciarcia R; Trepiccione F; Capasso G
    Nephrol Dial Transplant; 2024 Jan; 39(2):297-304. PubMed ID: 37463050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eltrombopag: a review of its use in treatment-refractory chronic primary immune thrombocytopenia.
    Garnock-Jones KP
    Drugs; 2011 Jul; 71(10):1333-53. PubMed ID: 21770480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eltrombopag plus cyclosporine in refractory immune thrombocytopenia: a single-center study.
    Hong Y; Shen Y; Liu Q; Dong J; Xiang J; Shen Y; Wu L; Zhou Y; Ye B; Wu D
    Res Pract Thromb Haemost; 2023 Jul; 7(5):100279. PubMed ID: 37456916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency and safety of eltrombopag for multi-line failed Chinese patients with immune thrombocytopenia: cases with decreased megakaryocyte response well from single-center experience.
    Liu Q; Shen Y; Li Y; Hu H; Liu W; Zhao Y; Dong H; Shen Y; Zhou Y; Ye B; Wu D
    Immunol Res; 2022 Feb; 70(1):67-74. PubMed ID: 34669176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia.
    Kim YK; Lee SS; Jeong SH; Ahn JS; Yang DH; Lee JJ; Kim HJ
    Blood Res; 2015 Mar; 50(1):19-25. PubMed ID: 25830126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Eltrombopag in Children With Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Giordano P; Lassandro G; Barone A; Cesaro S; Fotzi I; Giona F; Ladogana S; Miano M; Marzollo A; Nardi M; Notarangelo LD; Pession A; Ruggiero A; Russo G; Saracco P; Spinelli M; Tolva A; Tornesello A; Palladino V; Del Vecchio GC
    Front Med (Lausanne); 2020; 7():66. PubMed ID: 32181255
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.